DPLM.L (DPLM.L)

$7.9B
Market Cap
42.7
P/E Ratio
1.03
Beta
1.07%
Dividend Yield
Piotroski 7/9Altman Z 7.8 SafeROIC−WACC +3.5%

Quantitative Summary

Deterministic

Financial health metrics are strong: Piotroski 7/9, Altman Z 7.8 (above 3.0 safe zone threshold).

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation efficiency demonstrates a robust spread between the cost of equity and returns on invested capital, with an ROIC-WACC differential of 3.5% indicating value creation beyond hurdle rates. This economic moat is underpinned by high operating leverage, evidenced by gross margins expanding to 46.3% while net margins remain healthy at 12.1%. Financial stability metrics further corroborate this quality; a Piotroski F-Score of 7/9 signals strong fundamental improvements and balance sheet health, while an Altman Z-Score of 7.8 places the entity far into safe territory regarding bankruptcy risk. These factors collectively suggest that earnings power is driven by both margin expansion and efficient asset turnover rather than excessive leverage.

Valuation metrics present a significant divergence between current pricing and intrinsic value models. The market currently assigns a multiple of 42.7x to earnings, which represents a substantial premium relative to historical norms and implies aggressive growth expectations are already embedded in the price. This high multiple conflicts with the DCF-derived fair value estimate of $57, suggesting that if implied long-term growth assumptions hold true, current prices may be elevated; however, without specific forward P/E data or explicit growth rates used in the model, the gap between market price and intrinsic value remains a critical variable for assessing downside potential.

While no sector-specific peer comparisons are provided to contextualize the 42.7x multiple further, the combination of high Piotroski scores and strong ROIC suggests the company possesses durable competitive advantages that often justify premium valuations in growth phases. The risk profile appears low given the Altman score, yet the valuation gap between market price and DCF fair value introduces execution risk if revenue growth fails to meet the 11.8% trajectory required to sustain current multiples. Investors must weigh whether the market is pricing in a continuation of double-digit growth or anticipating a mean reversion that could compress valuations despite solid underlying fundamentals.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →8.9%10.9%12.9%
2%$68$51$40
3%$79$57$44
4%$93$64$48

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=10.9%, terminal growth 3%. Fair value $57 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

7/9
Piotroski F-Score
Strong — high operational efficiency and profitability signals
7.8
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.

Profitability & Value Creation

46.3%
Gross Margin
12.1%
Net Margin
14.3%
ROIC
10.9%
WACC
ROIC − WACC Spread: +3.5%— Positive spread.
+11.8%
Revenue Growth (YoY)
+43.0%
Earnings Growth (YoY)
253.2M
Free Cash Flow
32%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

Balance Sheet Health

0.82x
Debt / Equity
2.04x
Current Ratio
10.7x
Interest Coverage
1.0x
Net Debt / EBITDA
3.11%
FCF Yield
304.5M
EBITDA

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

25.2
Forward P/E
PEG Ratio
793.25
Price/Book
412727
Avg Volume
$6019.52
52W High
$3532.00
52W Low
52W Range Position

ETF Contagion Visualizer

Simulate a price drop in DPLM.L to visualize passive redemption contagion across ETFs and collateral stocks.

DPLM.L Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
DPLM.LEpicenterSCZETF5801.TLow Risk4004.TMed Risk5706.TLow RiskPLS.AXUnknownENLT.TAMed Risk
DPLM.L Price Drop (%)0

If DPLM.L (DPLM.L) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Furukawa Electric Co Ltd (5801.T) as the most exposed collateral stock, sharing 1 ETFs with DPLM.L. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 1 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

DPLM.L Ownership Dynamics

Ticker
DPLM.L

ETFs with Highest DPLM.L Exposure

Float lock-up computed from 0 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

DPLM.L Capital Efficiency

How efficiently does DPLM.L convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$253M
EBITDA
$305M
FCF Conversion
83%
Reinvestment Rate
17%
83% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
14.3%
ROIC − WACC Spread
3.5%

DPLM.L converts 83% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. The positive ROIC-WACC spread of 3.5% confirms that reinvested capital creates shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Compare DPLM.L to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.